Evidence map›Paper›PMID 26001649›Full record

ArticleVirology2015

ATM facilitates mouse gammaherpesvirus reactivation from myeloid cells during chronic infection.

Joseph M Kulinski, Eric J Darrah, Katarzyna A Broniowska, Wadzanai P Mboko, Bryan C Mounce, Laurent P Malherbe, John A Corbett, Stephen B Gauld, Vera L Tarakanova

Open access · greenAbstract read
In one paragraph

Article in Virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Joseph M KulinskiMicrobiology and Molecular Genetics, United States.
Eric J DarrahMicrobiology and Molecular Genetics, United States.
Katarzyna A BroniowskaBiochemistry, Medical College of Wisconsin, United States.
Wadzanai P MbokoMicrobiology and Molecular Genetics, United States.
Bryan C MounceMicrobiology and Molecular Genetics, United States.
Laurent P MalherbeBlood Research Institute, Blood Center of Wisconsin, United States.
John A CorbettBiochemistry, Medical College of Wisconsin, United States.
Stephen B GauldDivision of Allergy and Clinical Immunology, Department of Pediatrics, United States.
Vera L TarakanovaMicrobiology and Molecular Genetics, United States; Cancer Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, United States. Electronic address: vera@mcw.edu.
Medical College of Wisconsin · USNational Institute of Allergy and Infectious Diseases · USVersiti Blood Center of Wisconsin · US

Funding

MECHANISMS OF VIRAL INDUCED BETA CELL DAMAGER01AI044458 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CORBETT, JOHN A · 1998 to 2024
$7.5M
ATM and gammaherpesvirus infection: a precarious balanceR01CA183593 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI TARAKANOVA, VERA L. · 2014 to 2018
$1.6M
Modulation of histone deacetylase activity by a gammaherpesviral kinaseF31CA177279 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI MOUNCE, BRYAN C · 2013 to 2013
$33k
NCI NIH HHS 1F31CA177279-01NCI NIH HHS F31 CA177279NCI NIH HHS R01 CA183593NCI NIH HHS R01CA183593-01A1NIAID NIH HHS R01 AI044458
6 · The paper itself

Abstract

Gammaherpesviruses are cancer-associated pathogens that establish life-long infection in most adults. Insufficiency of Ataxia-Telangiectasia mutated (ATM) kinase leads to a poor control of chronic gammaherpesvirus infection via an unknown mechanism that likely involves a suboptimal antiviral response. In contrast to the phenotype in the intact host, ATM facilitates gammaherpesvirus reactivation and replication in vitro. We hypothesized that ATM mediates both pro- and antiviral activities to regulate chronic gammaherpesvirus infection in an immunocompetent host. To test the proposed proviral activity of ATM in vivo, we generated mice with ATM deficiency limited to myeloid cells. Myeloid-specific ATM deficiency attenuated gammaherpesvirus infection during the establishment of viral latency. The results of our study uncover a proviral role of ATM in the context of gammaherpesvirus infection in vivo and support a model where ATM combines pro- and antiviral functions to facilitate both gammaherpesvirus-specific T cell immune response and viral reactivation in vivo.

Indexed as

Virus ActivationAdultAnimalsAtaxia Telangiectasia Mutated ProteinsChronic DiseaseGammaherpesvirinaeHerpesviridae InfectionsHost-Pathogen InteractionsHumansMice, Inbred C57BLMice, KnockoutMyeloid CellsAtaxia Telangiectasia Mutated ProteinsAtm protein, mouseATMGammaherpesvirusMyeloid cellReactivationT cell response

Identifiers

PMID26001649
PMCPMC4516584
OpenAlexW295333479

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.